Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
free
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
free free
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve Pubget Overpricing |
lüll P21 and p27: roles in carcinogenesis and drug resistance Abukhdeir AM; Park BHExpert Rev Mol Med 2008[Jul]; 10 (ä): e19Human cancers arise from an imbalance of cell growth and cell death. Key proteins that govern this balance are those that mediate the cell cycle. Several different molecular effectors have been identified that tightly regulate specific phases of the cell cycle, including cyclins, cyclin-dependent kinases (CDKs) and CDK inhibitors. Notably, loss of expression or function of two G1-checkpoint CDK inhibitors - p21 (CDKN1A) and p27 (CDKN1B) - has been implicated in the genesis or progression of many human malignancies. Additionally, there is a growing body of evidence suggesting that functional loss of p21 or p27 can mediate a drug-resistance phenotype. However, reports in the literature have also suggested p21 and p27 can promote tumours, indicating a paradoxical effect. Here, we review historic and recent studies of these two CDK inhibitors, including their identification, function, importance to carcinogenesis and finally their roles in drug resistance.|*Drug Resistance, Neoplasm[MESH]|*Gene Expression Regulation, Neoplastic[MESH]|Animals[MESH]|Cell Cycle[MESH]|Cell Cycle Proteins/metabolism[MESH]|Cell Nucleus/metabolism[MESH]|Cyclin-Dependent Kinase Inhibitor p21/*physiology[MESH]|Cyclin-Dependent Kinase Inhibitor p27/*physiology[MESH]|Enzyme Inhibitors/pharmacology[MESH]|Humans[MESH]|Mice[MESH]|Mice, Knockout[MESH]|Neoplasms/*metabolism/pathology[MESH]|Prognosis[MESH] |